Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Pharmaceutical Sterile Sample Bags Market 2025 Driving Pharmaceutical Quality Standards
22 August 2025

Pharmaceutical Sterile Sample Bags Market 2025 Driving Pharmaceutical Quality Standards

Pharmaceutical Sterile Sample Bags Market Driving Next-Gen Pharma Safety According to Towards Packaging, the global pharmaceutical sterile sample bags market size was estimated at USD 1.50 billion in 2024 and is anticipated to reach around USD 1.88 billion by 2034, growing at a CAGR of 2.27 ...

Aprecia and Battelle Partner with DARPA and HHS for Agile Pharmaceutical Manufacturing
22 August 2025

Aprecia and Battelle Partner with DARPA and HHS for Agile Pharmaceutical Manufacturing

Aprecia and Battelle Partnered with the US Department of HHS and DARPA Announcement Aprecia and Battelle were granted a chance to collaborate with the US Defense Advanced Research Projects Agency (DARPA) as an award agreement to fuel the research program named ‘Establishing Qualification P...

Rady Children’s Institute Partners with Sidra Medicine to Launch Global Newborn Genome Screening
22 August 2025

Rady Children’s Institute Partners with Sidra Medicine to Launch Global Newborn Genome Screening

Rady to Enter an International Partnership with Sidra Medicine Announcement Rady Children’s Institute for Genomic Medicine (RCIGM) entered into a collaboration with Sidra Medicine, an excellent specialty healthcare organization for women, young people, and children in the state of Qatar. T...

Biotechs Adopt ‘Two-in-One’ Strategy to Target Multiple Diseases
22 August 2025

Biotechs Adopt ‘Two-in-One’ Strategy to Target Multiple Diseases

Biotechs Pursue a ‘Target Two Objectives With One Solution’ Strategy The History that Led to a Change in the Strategy From 2012 to 2020, AbbVie’s Humira, an excellent I and I, ranked as the most effective drug globally. The sales bar hit the growth level in 2022 in the times wh...

SkinMedica Launches HA5 Hydra Collagen Hydrating Foaming Cleanser for Deep Hydration
22 August 2025

SkinMedica Launches HA5 Hydra Collagen Hydrating Foaming Cleanser for Deep Hydration

SkinMedica® Reveals its Secret Hydration Formula Announcement Allergan Aesthetics, an AbbVie company, revealed its new addition to its SkinMedica HA5 hydra collagen portfolio. Focusing on the brand’s exclusivity, HA5 hydra collagen complex, a mixture of five forms of hyaluronic acid an...

VerticalVet and Zomedica Partner to Bring Advanced Veterinary Technologies to U.S. Practices
22 August 2025

VerticalVet and Zomedica Partner to Bring Advanced Veterinary Technologies to U.S. Practices

VerticalVet and Zomedica Entered a Collaborative Era Announcement Zomedica Corp., a veterinary health company providing therapeutic solutions and advanced diagnostics for equine and companion animals, has entered a partnership with Verticalvet, a reputable veterinary industry group purchasing or...

Opus Genetics Gets FDA Clearance for Gene Therapy Trial in Best Disease
21 August 2025

Opus Genetics Gets FDA Clearance for Gene Therapy Trial in Best Disease

Opus Genetics Received FDA Approval for the IND Application Announcement Opus Genetics leading clinical-stage biopharmaceutical company initiating gene therapies for inherited retinal disease (IRD) treatment and small molecule therapies for different ophthalmic disorders, received FDA clearanc...

IQVIA and Veeva Announce Global Commercial & Clinical Partnership, Resolve Legal Disputes
21 August 2025

IQVIA and Veeva Announce Global Commercial & Clinical Partnership, Resolve Legal Disputes

IQVIA and Veeva’s Global Commercial and Clinical Partnership and Clearance of Legal Disputes Announcement Veeva Systems and IQVIA entered a long-term commercial and clinical partnership and have completed settlement of all remaining legal issues. In this global agreement, the customers c...

PharmaCyte Biotech Secures $7 Million in Funding Through Securities Purchase Agreement
21 August 2025

PharmaCyte Biotech Secures $7 Million in Funding Through Securities Purchase Agreement

Pharmacyte Biotech Signed a Securities Purchase Agreement with Existing Investors  Announcement Pharmacyte Biotech Inc. has signed a securities purchase agreement worth $7.0 million under financial terms with existing investors, engaging the sale of 7,000 shares of its newly positioned Se...

Avixgen Signs $360 Million Licensing Deal with US Biotech Firm for Next-Gen Drug Delivery Platform
21 August 2025

Avixgen Signs $360 Million Licensing Deal with US Biotech Firm for Next-Gen Drug Delivery Platform

Subordinate of Dx&Vx Avixgen Entered a Licensing-out Agreement with a US Biotech Company  Announcement Avixgen, a secondary of Dx&Vx, declared on 18th August 2025 that it has entered a licensing out agreement at USD 360 million with a US biotechnology company to introduce a next-g...